These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 28670489)
1. Heat shock protein 70-2 (HSP70-2) a novel cancer testis antigen that promotes growth of ovarian cancer. Gupta N; Jagadish N; Surolia A; Suri A Am J Cancer Res; 2017; 7(6):1252-1269. PubMed ID: 28670489 [TBL] [Abstract][Full Text] [Related]
2. A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer. Jagadish N; Parashar D; Gupta N; Agarwal S; Purohit S; Kumar V; Sharma A; Fatima R; Topno AP; Shaha C; Suri A J Exp Clin Cancer Res; 2015 Nov; 34():142. PubMed ID: 26590805 [TBL] [Abstract][Full Text] [Related]
3. Sperm-associated antigen 9 (SPAG9) promotes the survival and tumor growth of triple-negative breast cancer cells. Jagadish N; Gupta N; Agarwal S; Parashar D; Sharma A; Fatima R; Topno AP; Kumar V; Suri A Tumour Biol; 2016 Oct; 37(10):13101-13110. PubMed ID: 27449044 [TBL] [Abstract][Full Text] [Related]
4. Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma. Jagadish N; Fatima R; Sharma A; Devi S; Suri V; Kumar V; Suri A Tumour Biol; 2018 May; 40(5):1010428318773652. PubMed ID: 29745297 [TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 70-2 (HSP70-2) overexpression in breast cancer. Jagadish N; Agarwal S; Gupta N; Fatima R; Devi S; Kumar V; Suri V; Kumar R; Suri V; Sadasukhi TC; Gupta A; Ansari AS; Lohiya NK; Suri A J Exp Clin Cancer Res; 2016 Sep; 35(1):150. PubMed ID: 27658496 [TBL] [Abstract][Full Text] [Related]
6. Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth. Jagadish N; Parashar D; Gupta N; Agarwal S; Suri V; Kumar R; Suri V; Sadasukhi TC; Gupta A; Ansari AS; Lohiya NK; Suri A BMC Cancer; 2016 Jul; 16():561. PubMed ID: 27473057 [TBL] [Abstract][Full Text] [Related]
7. Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo. Song K; Dai L; Long X; Cui X; Liu Y; Di W Onco Targets Ther; 2019; 12():4437-4449. PubMed ID: 31239712 [No Abstract] [Full Text] [Related]
8. Exosome Component 4 Promotes Epithelial Ovarian Cancer Cell Proliferation, Migration, and Invasion Xiong C; Sun Z; Yu J; Lin Y Front Oncol; 2021; 11():797968. PubMed ID: 34956910 [TBL] [Abstract][Full Text] [Related]
9. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer. Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970 [TBL] [Abstract][Full Text] [Related]
10. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6. Xia B; Yang S; Liu T; Lou G Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927 [TBL] [Abstract][Full Text] [Related]
11. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation. Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608 [TBL] [Abstract][Full Text] [Related]
12. Songorine suppresses cell growth and metastasis in epithelial ovarian cancer via the Bcl‑2/Bax and GSK3β/β‑catenin signaling pathways. Zhang H; Dong R; Zhang P; Wang Y Oncol Rep; 2019 May; 41(5):3069-3079. PubMed ID: 30896826 [TBL] [Abstract][Full Text] [Related]
13. LINC00968 accelerates the progression of epithelial ovarian cancer via mediating the cell cycle progression. Yao N; Sun JQ; Yu L; Ma L; Guo BQ Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4642-4649. PubMed ID: 31210289 [TBL] [Abstract][Full Text] [Related]
14. Ferulic acid decreases cell viability and colony formation while inhibiting migration of MIA PaCa-2 human pancreatic cancer cells in vitro. Fahrioğlu U; Dodurga Y; Elmas L; Seçme M Gene; 2016 Jan; 576(1 Pt 3):476-82. PubMed ID: 26516023 [TBL] [Abstract][Full Text] [Related]
15. The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells. Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Macdonald E; Vanderhyden B; Bachvarov D Oncotarget; 2016 Mar; 7(12):14125-42. PubMed ID: 26871602 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer. Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353 [TBL] [Abstract][Full Text] [Related]
17. The critical role of HMGA2 in regulation of EMT in epithelial ovarian carcinomas. Yan J; Zhang Y; Shi W; Ren C; Liu Y; Pan Y Tumour Biol; 2016 Jan; 37(1):823-8. PubMed ID: 26250458 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA growth arrest-specific transcript 5 is involved in ovarian cancer cell apoptosis through the mitochondria-mediated apoptosis pathway. Gao J; Liu M; Zou Y; Mao M; Shen T; Zhang C; Song S; Sun M; Zhang S; Wang B; Zhu D; Li P Oncol Rep; 2015 Dec; 34(6):3212-21. PubMed ID: 26503132 [TBL] [Abstract][Full Text] [Related]
19. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion. Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells. Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]